{"gene":"DLD","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":1997,"finding":"Targeted disruption of the murine Dld gene (encoding dihydrolipoamide dehydrogenase, the E3 subunit) results in perigastrulation lethality (embryonic death at ~E7.5), demonstrating that DLD is essential for embryonic development. Heterozygous animals show ~50% reduction in E3 activity and activity of all four affected multienzyme complexes (pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain alpha-ketoacid dehydrogenase, and glycine cleavage system) but are phenotypically normal, establishing that DLD is the shared E3 subunit for these four mitochondrial complexes.","method":"Homologous recombination gene knockout in mice; enzymatic activity assays for E3 and all four multienzyme complexes in heterozygous and homozygous animals","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — clean genetic knockout with defined embryonic lethal phenotype, enzymatic activity measurements across all four complexes confirming DLD as shared E3 component","pmids":["9405644"],"is_preprint":false},{"year":1993,"finding":"The human DLD gene encoding dihydrolipoamide dehydrogenase spans ~20 kb, contains 14 exons and 13 introns, and its 5' flanking region contains presumptive promoter elements including an Sp1 binding site, a nuclear respiratory factor 1 (NRF1) site, two cyclic AMP response element binding sites, and a negative response element similar to the insulin promoter. The 5' ends of mRNA transcripts upstream of the translation initiation codon were mapped by primer extension.","method":"Restriction endonuclease mapping, DNA sequencing of overlapping genomic clones, primer extension assay","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct structural genomics with primer extension mapping; single lab, multiple orthogonal methods","pmids":["8406489"],"is_preprint":false},{"year":2005,"finding":"A homozygous missense mutation c.1444A>G (p.R482G) in DLD exon 13 causes isolated alpha-ketoglutarate dehydrogenase complex (KGDC) deficiency (E3 activity ~20% of control) without the typical accumulation of pyruvate or branched-chain amino acids seen in E3 deficiency. This mutation, along with a previously described nearby mutation p.D479V, lies within the interface domain of the E3 subunit with the E2 subunit of KGDC and BCKDC, or the E3-binding protein of PDC, suggesting that interactions of E3 with these partner subunits differ among the three complexes.","method":"Enzymatic activity assay in cultured skin fibroblasts; RT-PCR and sequencing of E3 mRNA from patient fibroblasts","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — enzymatic assay with molecular diagnosis; single lab, two orthogonal methods (enzyme activity + sequencing); mechanistic inference about subunit interaction domain from mutation location","pmids":["15712224"],"is_preprint":false},{"year":2013,"finding":"Compound heterozygous DLD mutations (p.I353T and p.G136del) cause dihydrolipoamide dehydrogenase deficiency with E3 activity ranging from 9–29% of mean in cultured skin fibroblasts, presenting as Leigh syndrome with episodic encephalopathy and lactic ketoacidosis. This extends the clinical spectrum of DLD deficiency to include Leigh syndrome as a common associated neuropathology.","method":"Enzymatic activity assay in cultured skin fibroblasts; molecular analysis of DLD gene; plasma amino acid and urine organic acid analysis during decompensation","journal":"Pediatric neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — enzymatic confirmation with molecular diagnosis in single patient; single lab","pmids":["23290025"],"is_preprint":false},{"year":2019,"finding":"Mitochondrial dihydrolipoamide dehydrogenase (DLDH/DLD) functions as a redox enzyme involved in decarboxylation of pyruvate to acetyl-CoA during glucose metabolism and mitochondrial ATP production. Depending on physiological or pathophysiological conditions, DLDH can either enhance or attenuate production of reactive oxygen species (ROS) and reactive nitrogen species, positioning it as a potential therapeutic target for oxidative stress.","method":"Review of prior experimental work including inhibitor studies; mechanistic framework synthesis","journal":"Antioxidants","confidence":"Low","confidence_rationale":"Tier 4 / Weak — perspective/review article with no primary experimental data reported in the abstract","pmids":["30717346"],"is_preprint":false},{"year":2020,"finding":"Suppression of the dld-1 gene (C. elegans ortholog of DLD) in a C. elegans model expressing human Aβ peptide in muscles or neurons significantly restored vitality and function degraded by Aβ pathology, and reduced formation of toxic Aβ oligomers without reducing total Aβ peptide abundance. Proteomics after dld-1 suppression showed changes in energy metabolism and activation of pathways associated with proteasomal degradation, improved cell signaling, and longevity. A mitochondrial uncoupler (FCCP) that similarly inhibits ATP synthesis had no significant effect on Aβ toxicity, implying that features unique to dld-1 suppression (beyond reduced ATP) mediate the protective effect.","method":"RNAi-mediated dld-1 suppression in C. elegans Aβ model; behavioral/functional assays; quantification of Aβ oligomers; proteomics analysis; FCCP comparator experiment","journal":"Genes & diseases","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with defined phenotypic readout and orthogonal comparator (FCCP), plus proteomics; C. elegans ortholog study","pmids":["34522713"],"is_preprint":false},{"year":2023,"finding":"Knockdown of DLD expression in ovarian cancer cells suppressed intracellular NAD+/NADH ratio and consequently suppressed tumor cell proliferation, demonstrating that DLD regulates metabolic flux through the TCA cycle in cancer cells.","method":"siRNA knockdown of DLD; NAD+/NADH ratio measurement; MTT cell proliferation assay","journal":"Oncology letters","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single knockdown experiment with two readouts but no mechanistic depth beyond metabolic ratio","pmids":["37123026"],"is_preprint":false},{"year":2021,"finding":"DLD was identified as an interacting protein of CLTRN (collectrin) in HCC cells by co-immunoprecipitation, and the NRF1/RAN/DLD protein complex was proposed to act as an upstream regulator of CLTRN transcription. DLD was also linked to the glutathione metabolic pathway and ferroptosis signaling downstream of CLTRN overexpression.","method":"Co-immunoprecipitation; transcriptome sequencing (RNA-seq); in vitro and in vivo functional assays for ferroptosis markers","journal":"International journal of radiation oncology, biology, physics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — Co-IP identifying DLD as interacting protein is single method; mechanistic claims about DLD's role in the complex are not directly validated for DLD itself","pmids":["33508374"],"is_preprint":false},{"year":2018,"finding":"DLD (dihydrolipoamide dehydrogenase) expression was decreased after UVB exposure in keratinocytes, and paeonol promoted DLD production, which was associated with activation of the Nrf2/antioxidant response element (ARE) pathway and prevention of procollagen type I degradation. This places DLD upstream of Nrf2/ARE activation in the antioxidant response to UVB stress.","method":"Western blotting for DLD protein expression; Nrf2 nuclear accumulation assay; NQO1 and HO-1 expression measurement; in vivo mouse skin photoaging model","journal":"Phytotherapy research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — correlative relationship between DLD expression changes and Nrf2 activation; no direct manipulation of DLD to establish causality","pmids":["29748977"],"is_preprint":false}],"current_model":"DLD encodes the E3 subunit (dihydrolipoamide dehydrogenase) shared among four mitochondrial multienzyme complexes—pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain alpha-ketoacid dehydrogenase, and the glycine cleavage system—where it catalyzes oxidation of dihydrolipoyl moieties using FAD/NAD+ as cofactors; complete loss of DLD is embryonically lethal in mice, partial loss causes metabolic disease (lactic acidosis, organic acidemia, Leigh syndrome) in humans, and the protein modulates cellular ROS/NAD+/NADH balance and interacts with the Nrf2/ARE antioxidant pathway."},"narrative":{"mechanistic_narrative":"DLD encodes dihydrolipoamide dehydrogenase, the shared E3 flavoenzyme subunit common to four mitochondrial multienzyme complexes—pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase (KGDC), branched-chain alpha-ketoacid dehydrogenase, and the glycine cleavage system—as established genetically by murine knockout: complete loss causes perigastrulation embryonic lethality, while heterozygotes show coordinate ~50% reduction in E3 activity across all four complexes [PMID:9405644]. Through this E3 activity DLD contributes to pyruvate decarboxylation, TCA-cycle flux, and mitochondrial ATP production, and its loss in cancer cells lowers the NAD+/NADH ratio and suppresses proliferation, linking the enzyme to cellular redox and metabolic balance [PMID:37123026]. The protein interacts with partner E2 subunits and the E3-binding protein through an interface domain, and missense mutations clustering in this region (p.R482G, near p.D479V) can selectively impair KGDC, indicating that E3's engagement of its partner complexes is not uniform [PMID:15712224]. In humans, hypomorphic DLD mutations causing reduced E3 activity produce dihydrolipoamide dehydrogenase deficiency presenting as Leigh syndrome with episodic encephalopathy and lactic ketoacidosis [PMID:23290025]. The gene is transcriptionally configured for mitochondrial/respiratory function, with promoter elements including an NRF1 site [PMID:8406489].","teleology":[{"year":1993,"claim":"Before its regulation was understood, the genomic organization and promoter architecture of human DLD were undefined; mapping the gene established how this housekeeping mitochondrial enzyme is transcriptionally controlled.","evidence":"Restriction mapping, genomic sequencing, and primer extension of the human DLD locus","pmids":["8406489"],"confidence":"Medium","gaps":["Functional activity of the identified NRF1/Sp1/CRE elements not tested by reporter assays","Does not address protein function or enzymatic mechanism"]},{"year":1997,"claim":"It was unclear whether a single E3 subunit served all dihydrolipoamide-dependent complexes; knockout established DLD as the obligate shared E3 for four mitochondrial complexes and as essential for embryogenesis.","evidence":"Homologous-recombination knockout in mice with enzymatic assays of E3 and all four complexes","pmids":["9405644"],"confidence":"High","gaps":["Embryonic lethality precludes analysis of tissue-specific roles","Does not resolve how one E3 is shared among structurally distinct complexes"]},{"year":2005,"claim":"Whether E3 interacts identically with each partner complex was unknown; an interface-domain mutation causing isolated KGDC deficiency showed E3-partner interactions differ among complexes.","evidence":"Enzyme assays and DLD sequencing in patient fibroblasts identifying p.R482G in the E2/E3-binding interface","pmids":["15712224"],"confidence":"Medium","gaps":["Mechanism of selective KGDC impairment inferred from mutation location, not structurally resolved","Differential binding affinities not measured directly"]},{"year":2013,"claim":"The clinical range of DLD deficiency was incompletely defined; compound-heterozygous patients extended the spectrum to include Leigh syndrome.","evidence":"Enzymatic and molecular diagnosis in fibroblasts with metabolite profiling during decompensation","pmids":["23290025"],"confidence":"Medium","gaps":["Single patient; genotype-phenotype correlation not generalized","Does not establish why residual E3 activity yields Leigh-type neuropathology"]},{"year":2019,"claim":"Beyond catalysis, DLD's contribution to redox state was synthesized into a framework casting it as a bidirectional modulator of ROS/RNS and a possible oxidative-stress target.","evidence":"Review synthesis of prior inhibitor and mechanistic studies","pmids":["30717346"],"confidence":"Low","gaps":["Review without new primary data","Conditions determining ROS enhancement vs attenuation not defined experimentally here"]},{"year":2020,"claim":"Whether reducing DLD activity has consequences beyond ATP loss was open; ortholog suppression in a C. elegans Abeta model conferred protection distinct from a metabolic uncoupler.","evidence":"RNAi of dld-1 in Abeta worms with behavioral assays, Abeta-oligomer quantification, proteomics, and FCCP comparator","pmids":["34522713"],"confidence":"Medium","gaps":["Mechanism linking dld-1 loss to reduced Abeta oligomerization unresolved","Findings in worm ortholog not validated in mammalian neurons"]},{"year":2021,"claim":"DLD's potential involvement in transcriptional and ferroptosis circuitry was probed; it was identified as a CLTRN-interacting protein within a proposed NRF1/RAN/DLD complex linked to glutathione metabolism.","evidence":"Co-immunoprecipitation, RNA-seq, and ferroptosis-marker assays in HCC cells","pmids":["33508374"],"confidence":"Low","gaps":["Single Co-IP without reciprocal validation for DLD","DLD's specific contribution to the complex's regulatory activity not directly tested"]},{"year":2023,"claim":"DLD's role in cancer metabolism was tested; knockdown lowered the NAD+/NADH ratio and suppressed proliferation, tying it to TCA-cycle flux in tumor cells.","evidence":"siRNA knockdown with NAD+/NADH measurement and proliferation assay in ovarian cancer cells","pmids":["37123026"],"confidence":"Low","gaps":["Single knockdown experiment without rescue","Downstream effectors linking NAD+/NADH change to proliferation not identified"]},{"year":null,"claim":"How E3/DLD switches between enhancing and attenuating ROS, and how its interface selectively engages distinct partner complexes, remains mechanistically unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of complex-specific E3 docking in the timeline","Causal, redox-state-resolved control of ROS by DLD not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,4]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,4]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,4,6]}],"complexes":["pyruvate dehydrogenase complex","alpha-ketoglutarate dehydrogenase complex","branched-chain alpha-ketoacid dehydrogenase complex","glycine cleavage system"],"partners":["CLTRN","NRF1","RAN"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P09622","full_name":"Dihydrolipoyl dehydrogenase, mitochondrial","aliases":["Dihydrolipoamide dehydrogenase","Glycine cleavage system L protein"],"length_aa":509,"mass_kda":54.2,"function":"Lipoamide dehydrogenase is a component of the glycine cleavage system as well as an E3 component of three alpha-ketoacid dehydrogenase complexes (pyruvate-, alpha-ketoglutarate-, and branched-chain amino acid-dehydrogenase complex) (PubMed:15712224, PubMed:16442803, PubMed:16770810, PubMed:17404228, PubMed:20160912, PubMed:20385101). The 2-oxoglutarate dehydrogenase complex is mainly active in the mitochondrion (PubMed:29211711). A fraction of the 2-oxoglutarate dehydrogenase complex also localizes in the nucleus and is required for lysine succinylation of histones: associates with KAT2A on chromatin and provides succinyl-CoA to histone succinyltransferase KAT2A (PubMed:29211711). In monomeric form may have additional moonlighting function as serine protease (PubMed:17404228). Involved in the hyperactivation of spermatazoa during capacitation and in the spermatazoal acrosome reaction (By similarity). The pyruvate dehydrogenase (PDH) complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and thereby links cytoplasmic glycolysis and the mitochondrial tricarboxylic acid (TCA) cycle (Probable). It contains multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and dihydrolipoamide dehydrogenase (E3) (Probable). The E3 subunit catalyzes reoxidation of the dihydrolipoyl moiety on lipoyl-bearing domains (LBDs) of E2 with NAD+ as the ultimate electron acceptor (PubMed:16442803, PubMed:16770810, PubMed:20160912, PubMed:20385101)","subcellular_location":"Mitochondrion matrix; Nucleus; Cell projection, cilium, flagellum; Cytoplasmic vesicle, secretory vesicle, acrosome","url":"https://www.uniprot.org/uniprotkb/P09622/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DLD","classification":"Not Classified","n_dependent_lines":298,"n_total_lines":1208,"dependency_fraction":0.24668874172185432},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"PHGDH","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/DLD","total_profiled":1310},"omim":[{"mim_id":"618083","title":"WW-BINDING PROTEIN 11; WBP11","url":"https://www.omim.org/entry/618083"},{"mim_id":"617867","title":"TUMOR PROTEIN p53-INDUCIBLE PROTEIN 11; TP53I11","url":"https://www.omim.org/entry/617867"},{"mim_id":"616299","title":"LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D","url":"https://www.omim.org/entry/616299"},{"mim_id":"613022","title":"OXOGLUTARATE DEHYDROGENASE; OGDH","url":"https://www.omim.org/entry/613022"},{"mim_id":"609476","title":"NEMO-LIKE KINASE; NLK","url":"https://www.omim.org/entry/609476"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mitochondria","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Cytokinetic bridge","reliability":"Additional"},{"location":"Primary cilium","reliability":"Additional"},{"location":"Principal piece","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"skeletal muscle","ntpm":215.8},{"tissue":"tongue","ntpm":228.7}],"url":"https://www.proteinatlas.org/search/DLD"},"hgnc":{"alias_symbol":["DLDH","E3","OGDC-E3"],"prev_symbol":["LAD","GCSL"]},"alphafold":{"accession":"P09622","domains":[{"cath_id":"3.50.50.60","chopping":"36-185_316-377","consensus_level":"high","plddt":98.0343,"start":36,"end":377},{"cath_id":"3.50.50.60","chopping":"199-313","consensus_level":"high","plddt":97.7715,"start":199,"end":313},{"cath_id":"3.30.390.30","chopping":"390-502","consensus_level":"high","plddt":98.7359,"start":390,"end":502}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P09622","model_url":"https://alphafold.ebi.ac.uk/files/AF-P09622-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P09622-F1-predicted_aligned_error_v6.png","plddt_mean":94.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DLD","jax_strain_url":"https://www.jax.org/strain/search?query=DLD"},"sequence":{"accession":"P09622","fasta_url":"https://rest.uniprot.org/uniprotkb/P09622.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P09622/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P09622"}},"corpus_meta":[{"pmid":"12801524","id":"PMC_12801524","title":"Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI.","date":"2003","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/12801524","citation_count":445,"is_preprint":false},{"pmid":"19064721","id":"PMC_19064721","title":"LAD-1/variant syndrome is caused by mutations in FERMT3.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19064721","citation_count":174,"is_preprint":false},{"pmid":"19751532","id":"PMC_19751532","title":"Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells.","date":"2009","source":"Virology journal","url":"https://pubmed.ncbi.nlm.nih.gov/19751532","citation_count":135,"is_preprint":false},{"pmid":"9776360","id":"PMC_9776360","title":"Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-kappaB-signaling pathways.","date":"1998","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9776360","citation_count":124,"is_preprint":false},{"pmid":"11073940","id":"PMC_11073940","title":"MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11073940","citation_count":122,"is_preprint":false},{"pmid":"17576779","id":"PMC_17576779","title":"A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets.","date":"2007","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17576779","citation_count":116,"is_preprint":false},{"pmid":"23061912","id":"PMC_23061912","title":"Antiproliferative and proapoptotic effects of viable or heat-killed Lactobacillus paracasei IMPC2.1 and Lactobacillus rhamnosus GG in HGC-27 gastric and DLD-1 colon cell lines.","date":"2012","source":"Nutrition and cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23061912","citation_count":106,"is_preprint":false},{"pmid":"16112579","id":"PMC_16112579","title":"Xanthones induce cell-cycle arrest and apoptosis in human colon cancer DLD-1 cells.","date":"2005","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16112579","citation_count":105,"is_preprint":false},{"pmid":"11502758","id":"PMC_11502758","title":"LAD-1, the Caenorhabditis elegans L1CAM homologue, participates in embryonic and gonadal morphogenesis and is a substrate for fibroblast growth factor receptor pathway-dependent phosphotyrosine-based signaling.","date":"2001","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11502758","citation_count":100,"is_preprint":false},{"pmid":"11313989","id":"PMC_11313989","title":"p53 upregulates cFLIP, inhibits transcription of NF-kappaB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells.","date":"2001","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11313989","citation_count":93,"is_preprint":false},{"pmid":"17185466","id":"PMC_17185466","title":"Natural history and early diagnosis of LAD-1/variant syndrome.","date":"2006","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17185466","citation_count":86,"is_preprint":false},{"pmid":"12640115","id":"PMC_12640115","title":"MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12640115","citation_count":83,"is_preprint":false},{"pmid":"19617577","id":"PMC_19617577","title":"Loss of Kindlin-3 in LAD-III eliminates LFA-1 but not VLA-4 adhesiveness developed under shear flow conditions.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19617577","citation_count":83,"is_preprint":false},{"pmid":"10936446","id":"PMC_10936446","title":"Genetic analysis of integrin function in man: LAD-1 and other syndromes.","date":"2000","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/10936446","citation_count":81,"is_preprint":false},{"pmid":"15712224","id":"PMC_15712224","title":"A novel mutation in the dihydrolipoamide dehydrogenase E3 subunit gene (DLD) resulting in an atypical form of alpha-ketoglutarate dehydrogenase deficiency.","date":"2005","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/15712224","citation_count":75,"is_preprint":false},{"pmid":"16900341","id":"PMC_16900341","title":"Dementia lacking distinctive histology (DLDH) revisited.","date":"2006","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/16900341","citation_count":72,"is_preprint":false},{"pmid":"14552841","id":"PMC_14552841","title":"LAD-III, a novel group of leukocyte integrin activation deficiencies.","date":"2003","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/14552841","citation_count":72,"is_preprint":false},{"pmid":"9405644","id":"PMC_9405644","title":"Targeted disruption of the murine dihydrolipoamide dehydrogenase gene (Dld) results in perigastrulation lethality.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9405644","citation_count":71,"is_preprint":false},{"pmid":"8492799","id":"PMC_8492799","title":"Isolation of the DLD gene of Saccharomyces cerevisiae encoding the mitochondrial enzyme D-lactate ferricytochrome c oxidoreductase.","date":"1993","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/8492799","citation_count":70,"is_preprint":false},{"pmid":"9147612","id":"PMC_9147612","title":"Activation of the retinoic acid receptor beta gene by 5-aza-2'-deoxycytidine in human DLD-1 colon carcinoma cells.","date":"1997","source":"Anti-cancer drugs","url":"https://pubmed.ncbi.nlm.nih.gov/9147612","citation_count":68,"is_preprint":false},{"pmid":"11076874","id":"PMC_11076874","title":"Inhibition of inducible nitric oxide synthase in the human intestinal epithelial cell line, DLD-1, by the inducers of heme oxygenase 1, bismuth salts, heme, and nitric oxide donors.","date":"2000","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/11076874","citation_count":62,"is_preprint":false},{"pmid":"17875809","id":"PMC_17875809","title":"Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1).","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17875809","citation_count":61,"is_preprint":false},{"pmid":"18195110","id":"PMC_18195110","title":"The C. elegans L1CAM homologue LAD-2 functions as a coreceptor in MAB-20/Sema2 mediated axon guidance.","date":"2008","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18195110","citation_count":58,"is_preprint":false},{"pmid":"10553045","id":"PMC_10553045","title":"Lad, an adapter protein interacting with the SH2 domain of p56lck, is required for T cell activation.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10553045","citation_count":57,"is_preprint":false},{"pmid":"22529978","id":"PMC_22529978","title":"GRP78 knockdown enhances apoptosis via the down-regulation of oxidative stress and Akt pathway after epirubicin treatment in colon cancer DLD-1 cells.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22529978","citation_count":53,"is_preprint":false},{"pmid":"7621404","id":"PMC_7621404","title":"DLD-1 and HCT-15 cell lines derived separately from colorectal carcinomas have totally different chromosome changes but the same genetic origin.","date":"1995","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/7621404","citation_count":52,"is_preprint":false},{"pmid":"12901858","id":"PMC_12901858","title":"Nemo-like kinase induces apoptosis in DLD-1 human colon cancer cells.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12901858","citation_count":51,"is_preprint":false},{"pmid":"10086335","id":"PMC_10086335","title":"Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells.","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10086335","citation_count":49,"is_preprint":false},{"pmid":"10886250","id":"PMC_10886250","title":"A novel point mutation in CD18 causing the expression of dysfunctional CD11/CD18 leucocyte integrins in a patient with leucocyte adhesion deficiency (LAD).","date":"2000","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10886250","citation_count":49,"is_preprint":false},{"pmid":"21161820","id":"PMC_21161820","title":"Estrogen receptor-β mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones.","date":"2011","source":"Nutrition and cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21161820","citation_count":48,"is_preprint":false},{"pmid":"16093613","id":"PMC_16093613","title":"Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin- and MAP kinase-dependent manners.","date":"2005","source":"Journal of pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/16093613","citation_count":47,"is_preprint":false},{"pmid":"14556662","id":"PMC_14556662","title":"Characterization of cell death induced by ethacrynic acid in a human colon cancer cell line DLD-1 and suppression by N-acetyl-L-cysteine.","date":"2003","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/14556662","citation_count":47,"is_preprint":false},{"pmid":"19234959","id":"PMC_19234959","title":"Effects of Lactobacillus rhamnosus GG on proliferation and polyamine metabolism in HGC-27 human gastric and DLD-1 colonic cancer cell lines.","date":"2009","source":"Immunopharmacology and immunotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/19234959","citation_count":47,"is_preprint":false},{"pmid":"22641662","id":"PMC_22641662","title":"KRAS up-regulates the expression of miR-181a, miR-200c and miR-210 in a three-dimensional-specific manner in DLD-1 colorectal cancer cells.","date":"2012","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/22641662","citation_count":46,"is_preprint":false},{"pmid":"23290025","id":"PMC_23290025","title":"Leigh syndrome in a girl with a novel DLD mutation causing E3 deficiency.","date":"2013","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23290025","citation_count":41,"is_preprint":false},{"pmid":"33508374","id":"PMC_33508374","title":"CLTRN, Regulated by NRF1/RAN/DLD Protein Complex, Enhances Radiation Sensitivity of Hepatocellular Carcinoma Cells Through Ferroptosis Pathway.","date":"2021","source":"International journal of radiation oncology, biology, physics","url":"https://pubmed.ncbi.nlm.nih.gov/33508374","citation_count":40,"is_preprint":false},{"pmid":"29748977","id":"PMC_29748977","title":"Paeonol extracted from Paeonia suffruticosa Andr. ameliorated UVB-induced skin photoaging via DLD/Nrf2/ARE and MAPK/AP-1 pathway.","date":"2018","source":"Phytotherapy research : PTR","url":"https://pubmed.ncbi.nlm.nih.gov/29748977","citation_count":40,"is_preprint":false},{"pmid":"36871147","id":"PMC_36871147","title":"Robust Spontaneous Raman Flow Cytometry for Single-Cell Metabolic Phenome Profiling via pDEP-DLD-RFC.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/36871147","citation_count":39,"is_preprint":false},{"pmid":"29615695","id":"PMC_29615695","title":"GLYI and D-LDH play key role in methylglyoxal detoxification and abiotic stress tolerance.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29615695","citation_count":39,"is_preprint":false},{"pmid":"32904616","id":"PMC_32904616","title":"AMPK/mTOR/ULK1 Axis-Mediated Pathway Participates in Apoptosis and Autophagy Induction by Oridonin in Colon Cancer DLD-1 Cells.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32904616","citation_count":38,"is_preprint":false},{"pmid":"11703376","id":"PMC_11703376","title":"Characterization of four CD18 mutants in leucocyte adhesion deficient (LAD) patients with differential capacities to support expression and function of the CD11/CD18 integrins LFA-1, Mac-1 and p150,95.","date":"2001","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11703376","citation_count":38,"is_preprint":false},{"pmid":"28342178","id":"PMC_28342178","title":"Return of the lysergamides. Part III: Analytical characterization of N6 -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD).","date":"2017","source":"Drug testing and analysis","url":"https://pubmed.ncbi.nlm.nih.gov/28342178","citation_count":36,"is_preprint":false},{"pmid":"29496963","id":"PMC_29496963","title":"Quantitative proteomic and phosphoproteomic comparison of human colon cancer DLD-1 cells differing in ploidy and chromosome stability.","date":"2018","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/29496963","citation_count":36,"is_preprint":false},{"pmid":"14511767","id":"PMC_14511767","title":"MAP kinase-mediated proliferation of DLD-1 carcinoma by the stimulation of protease-activated receptor 2.","date":"2003","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/14511767","citation_count":35,"is_preprint":false},{"pmid":"19141699","id":"PMC_19141699","title":"Soy isoflavones modulate azoxymethane-induced rat colon carcinogenesis exposed pre- and postnatally and inhibit growth of DLD-1 human colon adenocarcinoma cells by increasing the expression of estrogen receptor-beta.","date":"2009","source":"The Journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/19141699","citation_count":33,"is_preprint":false},{"pmid":"9605580","id":"PMC_9605580","title":"Involvement of protein kinases in the induction of NO synthase II in human DLD-1 cells.","date":"1998","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9605580","citation_count":32,"is_preprint":false},{"pmid":"30717346","id":"PMC_30717346","title":"Chronic Inhibition of Mitochondrial Dihydrolipoamide Dehydrogenase (DLDH) as an Approach to Managing Diabetic Oxidative Stress.","date":"2019","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/30717346","citation_count":31,"is_preprint":false},{"pmid":"33920455","id":"PMC_33920455","title":"Human Endogenous Retrovirus (HERV)-K env Gene Knockout Affects Tumorigenic Characteristics of nupr1 Gene in DLD-1 Colorectal Cancer Cells.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33920455","citation_count":30,"is_preprint":false},{"pmid":"12151344","id":"PMC_12151344","title":"Expression of interleukin-8, heme oxygenase-1 and vascular endothelial growth factor in DLD-1 colon carcinoma cells exposed to pyrrolidine dithiocarbamate.","date":"2002","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/12151344","citation_count":30,"is_preprint":false},{"pmid":"20944129","id":"PMC_20944129","title":"Quercetin inhibits human DLD-1 colon cancer cell growth and polyamine biosynthesis.","date":"2010","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/20944129","citation_count":29,"is_preprint":false},{"pmid":"26562319","id":"PMC_26562319","title":"Identification of DLD, by immunoproteomic analysis and evaluation as a potential vaccine antigen against three Vibrio species in Epinephelus coioides.","date":"2015","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/26562319","citation_count":29,"is_preprint":false},{"pmid":"27543111","id":"PMC_27543111","title":"Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.","date":"2016","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27543111","citation_count":29,"is_preprint":false},{"pmid":"35082255","id":"PMC_35082255","title":"Predicting Values of Neutrophil-to-Lymphocyte Ratio (NLR), High-Sensitivity C-Reactive Protein (hs-CRP), and Left Atrial Diameter (LAD) in Patients with Nonvalvular Atrial Fibrillation Recurrence After Radiofrequency Ablation.","date":"2022","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/35082255","citation_count":28,"is_preprint":false},{"pmid":"16216547","id":"PMC_16216547","title":"Polyunsaturated fatty acids inhibit telomerase activity in DLD-1 human colorectal adenocarcinoma cells: a dual mechanism approach.","date":"2005","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/16216547","citation_count":28,"is_preprint":false},{"pmid":"21159175","id":"PMC_21159175","title":"Quinone-dependent D-lactate dehydrogenase Dld (Cg1027) is essential for growth of Corynebacterium glutamicum on D-lactate.","date":"2010","source":"BMC microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/21159175","citation_count":27,"is_preprint":false},{"pmid":"25096395","id":"PMC_25096395","title":"Apoptotic Effects of Quercitrin on DLD-1 Colon Cancer Cell Line.","date":"2014","source":"Pathology oncology research : POR","url":"https://pubmed.ncbi.nlm.nih.gov/25096395","citation_count":27,"is_preprint":false},{"pmid":"16293557","id":"PMC_16293557","title":"Estrogenic regulation of cholesterol biosynthesis and cell growth in DLD-1 human colon cancer cells.","date":"2005","source":"Scandinavian journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/16293557","citation_count":26,"is_preprint":false},{"pmid":"35408940","id":"PMC_35408940","title":"Understanding the Role of LFA-1 in Leukocyte Adhesion Deficiency Type I (LAD I): Moving towards Inflammation?","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35408940","citation_count":26,"is_preprint":false},{"pmid":"16091008","id":"PMC_16091008","title":"Effects of genistein on the polyamine metabolism and cell growth in DLD-1 human colon cancer cells.","date":"2005","source":"Nutrition and cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16091008","citation_count":26,"is_preprint":false},{"pmid":"22065596","id":"PMC_22065596","title":"Defects in Glanzmann thrombasthenia and LAD-III (LAD-1/v) syndrome: the role of integrin β1 and β3 in platelet adhesion to collagen.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/22065596","citation_count":25,"is_preprint":false},{"pmid":"22369729","id":"PMC_22369729","title":"Localization and phototoxic effect of zinc sulfophthalocyanine photosensitizer in human colon (DLD-1) and lung (A549) carcinoma cells (in vitro).","date":"2011","source":"Photodiagnosis and photodynamic therapy","url":"https://pubmed.ncbi.nlm.nih.gov/22369729","citation_count":25,"is_preprint":false},{"pmid":"31933046","id":"PMC_31933046","title":"Altered brain structures in the dorsal and ventral language pathways in individuals with and without developmental language disorder (DLD).","date":"2020","source":"Brain imaging and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/31933046","citation_count":24,"is_preprint":false},{"pmid":"34522713","id":"PMC_34522713","title":"Suppression of a core metabolic enzyme dihydrolipoamide dehydrogenase (dld) protects against amyloid beta toxicity in C. elegans model of Alzheimer's disease.","date":"2020","source":"Genes & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/34522713","citation_count":24,"is_preprint":false},{"pmid":"9284104","id":"PMC_9284104","title":"LAD-1 is absent in a subset of junctional epidermolysis bullosa patients.","date":"1997","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/9284104","citation_count":23,"is_preprint":false},{"pmid":"35242234","id":"PMC_35242234","title":"PI3K/Akt/YAP signaling promotes migration and invasion of DLD-1 colorectal cancer cells.","date":"2022","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/35242234","citation_count":22,"is_preprint":false},{"pmid":"10446104","id":"PMC_10446104","title":"Potentiation of cytokine induced iNOS expression in the human intestinal epithelial cell line, DLD-1, by cyclic AMP.","date":"1999","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/10446104","citation_count":22,"is_preprint":false},{"pmid":"23505557","id":"PMC_23505557","title":"Human Mas-related G protein-coupled receptors-X1 induce chemokine receptor 2 expression in rat dorsal root ganglia neurons and release of chemokine ligand 2 from the human LAD-2 mast cell line.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23505557","citation_count":22,"is_preprint":false},{"pmid":"9543252","id":"PMC_9543252","title":"Adenosine modulates cell proliferation in human colonic carcinoma. II. Differential behavior of HT29, DLD-1, Caco-2 and SW403 cell lines.","date":"1998","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9543252","citation_count":22,"is_preprint":false},{"pmid":"38059693","id":"PMC_38059693","title":"Speech sound disorder or DLD (phonology)? Towards a consensus agreement on terminology.","date":"2023","source":"International journal of language & communication disorders","url":"https://pubmed.ncbi.nlm.nih.gov/38059693","citation_count":21,"is_preprint":false},{"pmid":"26617761","id":"PMC_26617761","title":"Perfluorooctanoic acid enhances colorectal cancer DLD-1 cells invasiveness through activating NF-κB mediated matrix metalloproteinase-2/-9 expression.","date":"2015","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26617761","citation_count":21,"is_preprint":false},{"pmid":"8406489","id":"PMC_8406489","title":"The structure of the human dihydrolipoamide dehydrogenase gene (DLD) and its upstream elements.","date":"1993","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8406489","citation_count":21,"is_preprint":false},{"pmid":"32717981","id":"PMC_32717981","title":"The Effect of Novel 7-methyl-5-phenyl-pyrazolo[4,3-e]tetrazolo[4,5-b][1,2,4]triazine Sulfonamide Derivatives on Apoptosis and Autophagy in DLD-1 and HT-29 Colon Cancer Cells.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32717981","citation_count":21,"is_preprint":false},{"pmid":"12377933","id":"PMC_12377933","title":"Defective migration of monocyte-derived dendritic cells in LAD-1 immunodeficiency.","date":"2002","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/12377933","citation_count":21,"is_preprint":false},{"pmid":"14706850","id":"PMC_14706850","title":"High and low affinity receptors mediate growth effects of gastrin and gastrin-Gly on DLD-1 human colonic carcinoma cells.","date":"2004","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/14706850","citation_count":20,"is_preprint":false},{"pmid":"17327418","id":"PMC_17327418","title":"The adaptor protein Lad associates with the G protein beta subunit and mediates chemokine-dependent T-cell migration.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17327418","citation_count":20,"is_preprint":false},{"pmid":"9130592","id":"PMC_9130592","title":"Analysis of expression and promoter function of the human inducible nitric oxide synthase gene in DLD-1 cells and monkey hepatocytes.","date":"1997","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9130592","citation_count":20,"is_preprint":false},{"pmid":"12692863","id":"PMC_12692863","title":"5-Fluorouracil efficiently enhanced apoptosis induced by adenovirus-mediated transfer of caspase-8 in DLD-1 colon cancer cells.","date":"2003","source":"The journal of gene medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12692863","citation_count":20,"is_preprint":false},{"pmid":"9657039","id":"PMC_9657039","title":"Mechanisms for 5-fluorouracil resistance in human colon cancer DLD-1 cells.","date":"1998","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/9657039","citation_count":20,"is_preprint":false},{"pmid":"37123026","id":"PMC_37123026","title":"Oncogenic role of copper‑induced cell death‑associated protein DLD in human cancer: A pan‑cancer analysis and experimental verification.","date":"2023","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/37123026","citation_count":19,"is_preprint":false},{"pmid":"25922072","id":"PMC_25922072","title":"Gastrin-stimulated Gα13 Activation of Rgnef Protein (ArhGEF28) in DLD-1 Colon Carcinoma Cells.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25922072","citation_count":19,"is_preprint":false},{"pmid":"21034658","id":"PMC_21034658","title":"Anthocyanins extracted from Chinese blueberry (Vaccinium uliginosum L.) and its anticancer effects on DLD-1 and COLO205 cells.","date":"2010","source":"Chinese medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/21034658","citation_count":19,"is_preprint":false},{"pmid":"29737584","id":"PMC_29737584","title":"Metformin increases the cytotoxicity of oxaliplatin in human DLD-1 colorectal cancer cells through down-regulating HMGB1 expression.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29737584","citation_count":19,"is_preprint":false},{"pmid":"15504750","id":"PMC_15504750","title":"The HIV protease inhibitor ritonavir synergizes with butyrate for induction of apoptotic cell death and mediates expression of heme oxygenase-1 in DLD-1 colon carcinoma cells.","date":"2004","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15504750","citation_count":19,"is_preprint":false},{"pmid":"37228705","id":"PMC_37228705","title":"The pathogenesis of DLD-mediated cuproptosis induced spinal cord injury and its regulation on immune microenvironment.","date":"2023","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/37228705","citation_count":18,"is_preprint":false},{"pmid":"24055891","id":"PMC_24055891","title":"Different susceptibility of colon cancer DLD-1 and LOVO cell lines to apoptosis induced by DMU-212, a synthetic resveratrol analogue.","date":"2013","source":"Toxicology in vitro : an international journal published in association with BIBRA","url":"https://pubmed.ncbi.nlm.nih.gov/24055891","citation_count":18,"is_preprint":false},{"pmid":"23266613","id":"PMC_23266613","title":"p38MAPK and Rho-dependent kinase are involved in anoikis induced by anicequol or 25-hydroxycholesterol in DLD-1 colon cancer cells.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23266613","citation_count":18,"is_preprint":false},{"pmid":"25292312","id":"PMC_25292312","title":"Efficient apoptosis and necrosis induction by proteasome inhibitor: bortezomib in the DLD-1 human colon cancer cell line.","date":"2014","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25292312","citation_count":18,"is_preprint":false},{"pmid":"35437578","id":"PMC_35437578","title":"To be or not be (in the LAD): emerging roles of lamin proteins in transcriptional regulation.","date":"2022","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/35437578","citation_count":17,"is_preprint":false},{"pmid":"30473630","id":"PMC_30473630","title":"RelB plays an oncogenic role and conveys chemo-resistance to DLD-1 colon cancer cells.","date":"2018","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/30473630","citation_count":17,"is_preprint":false},{"pmid":"11394873","id":"PMC_11394873","title":"Adaptor protein Lad relays PDGF signal to Grb2 in lung cells: a tissue-specific PDGF signal transduction.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11394873","citation_count":17,"is_preprint":false},{"pmid":"12490281","id":"PMC_12490281","title":"Cloning MafF by recognition site screening with the NFE2 tandem repeat of HS2: analysis of its role in globin and GCSl genes regulation.","date":"2002","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/12490281","citation_count":16,"is_preprint":false},{"pmid":"37702123","id":"PMC_37702123","title":"Scalable mesenchymal stem cell enrichment from bone marrow aspirate using deterministic lateral displacement (DLD) microfluidic sorting.","date":"2023","source":"Lab on a chip","url":"https://pubmed.ncbi.nlm.nih.gov/37702123","citation_count":16,"is_preprint":false},{"pmid":"38667167","id":"PMC_38667167","title":"A Novel Microfluidic Strategy for Efficient Exosome Separation via Thermally Oxidized Non-Uniform Deterministic Lateral Displacement (DLD) Arrays and Dielectrophoresis (DEP) Synergy.","date":"2024","source":"Biosensors","url":"https://pubmed.ncbi.nlm.nih.gov/38667167","citation_count":16,"is_preprint":false},{"pmid":"28955947","id":"PMC_28955947","title":"Snail1 expression in human colon cancer DLD-1 cells confers invasive properties without N-cadherin expression.","date":"2016","source":"Biochemistry and biophysics reports","url":"https://pubmed.ncbi.nlm.nih.gov/28955947","citation_count":15,"is_preprint":false},{"pmid":"22139635","id":"PMC_22139635","title":"Leukocyte adhesion deficiency-I variant syndrome (LAD-Iv, LAD-III): molecular characterization of the defect in an index family.","date":"2011","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/22139635","citation_count":15,"is_preprint":false},{"pmid":"36353455","id":"PMC_36353455","title":"Molecular mechanisms of plant growth promotion for methylotrophic Bacillus aryabhattai LAD.","date":"2022","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/36353455","citation_count":14,"is_preprint":false},{"pmid":"16546964","id":"PMC_16546964","title":"Novel missense mutation of the DNA topoisomerase I gene in SN-38-resistant DLD-1 cells.","date":"2006","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/16546964","citation_count":14,"is_preprint":false},{"pmid":"11551823","id":"PMC_11551823","title":"Identification of a 70-kDa gastrin-binding protein on DLD-1 human colorectal carcinoma cells.","date":"2001","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11551823","citation_count":14,"is_preprint":false},{"pmid":"37373005","id":"PMC_37373005","title":"Anti-Cancer Roles of Probiotic-Derived P8 Protein in Colorectal Cancer Cell Line DLD-1.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37373005","citation_count":13,"is_preprint":false},{"pmid":"35603593","id":"PMC_35603593","title":"Bacillus aryabhattai LAD impacts rhizosphere bacterial community structure and promotes maize plant growth.","date":"2022","source":"Journal of the science of food and agriculture","url":"https://pubmed.ncbi.nlm.nih.gov/35603593","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52319,"output_tokens":2991,"usd":0.100911,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9902,"output_tokens":2785,"usd":0.059568,"stage2_stop_reason":"end_turn"},"total_usd":0.160479,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"Looking through the abstracts, I need to identify papers about the canonical DLD gene (dihydrolipoamide dehydrogenase, E3 subunit of mitochondrial multienzyme complexes). Many papers use \"DLD\" to refer to cell lines (DLD-1 colorectal cancer cells), \"LAD\" as an alias for various unrelated proteins (leukocyte adhesion deficiency, L1CAM homolog in C. elegans, adapter proteins), or \"DLD\" in other contexts (deterministic lateral displacement microfluidics, developmental language disorder, etc.).\n\nPapers about the canonical DLD protein (dihydrolipoamide dehydrogenase):\n- PMID 15712224: DLD mutations causing E3 deficiency (mechanistic)\n- PMID 9405644: Murine Dld knockout (mechanistic)\n- PMID 8406489: DLD gene structure\n- PMID 23290025: Novel DLD mutation causing E3 deficiency\n- PMID 30717346: DLDH as redox enzyme, ROS production\n- PMID 34522713: C. elegans dld-1 suppression in Alzheimer's model\n- PMID 33508374: DLD as interacting protein with CLTRN (mechanistic claim but weak)\n- PMID 37123026: DLD pan-cancer, NAD+/NADH regulation\n- PMID 29748977: DLD and Nrf2/ARE pathway in UVB photoaging\n- PMID 37228705: DLD in cuproptosis/spinal cord injury\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"Targeted disruption of the murine Dld gene (encoding dihydrolipoamide dehydrogenase, the E3 subunit) results in perigastrulation lethality (embryonic death at ~E7.5), demonstrating that DLD is essential for embryonic development. Heterozygous animals show ~50% reduction in E3 activity and activity of all four affected multienzyme complexes (pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain alpha-ketoacid dehydrogenase, and glycine cleavage system) but are phenotypically normal, establishing that DLD is the shared E3 subunit for these four mitochondrial complexes.\",\n      \"method\": \"Homologous recombination gene knockout in mice; enzymatic activity assays for E3 and all four multienzyme complexes in heterozygous and homozygous animals\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — clean genetic knockout with defined embryonic lethal phenotype, enzymatic activity measurements across all four complexes confirming DLD as shared E3 component\",\n      \"pmids\": [\"9405644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The human DLD gene encoding dihydrolipoamide dehydrogenase spans ~20 kb, contains 14 exons and 13 introns, and its 5' flanking region contains presumptive promoter elements including an Sp1 binding site, a nuclear respiratory factor 1 (NRF1) site, two cyclic AMP response element binding sites, and a negative response element similar to the insulin promoter. The 5' ends of mRNA transcripts upstream of the translation initiation codon were mapped by primer extension.\",\n      \"method\": \"Restriction endonuclease mapping, DNA sequencing of overlapping genomic clones, primer extension assay\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct structural genomics with primer extension mapping; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"8406489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"A homozygous missense mutation c.1444A>G (p.R482G) in DLD exon 13 causes isolated alpha-ketoglutarate dehydrogenase complex (KGDC) deficiency (E3 activity ~20% of control) without the typical accumulation of pyruvate or branched-chain amino acids seen in E3 deficiency. This mutation, along with a previously described nearby mutation p.D479V, lies within the interface domain of the E3 subunit with the E2 subunit of KGDC and BCKDC, or the E3-binding protein of PDC, suggesting that interactions of E3 with these partner subunits differ among the three complexes.\",\n      \"method\": \"Enzymatic activity assay in cultured skin fibroblasts; RT-PCR and sequencing of E3 mRNA from patient fibroblasts\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — enzymatic assay with molecular diagnosis; single lab, two orthogonal methods (enzyme activity + sequencing); mechanistic inference about subunit interaction domain from mutation location\",\n      \"pmids\": [\"15712224\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Compound heterozygous DLD mutations (p.I353T and p.G136del) cause dihydrolipoamide dehydrogenase deficiency with E3 activity ranging from 9–29% of mean in cultured skin fibroblasts, presenting as Leigh syndrome with episodic encephalopathy and lactic ketoacidosis. This extends the clinical spectrum of DLD deficiency to include Leigh syndrome as a common associated neuropathology.\",\n      \"method\": \"Enzymatic activity assay in cultured skin fibroblasts; molecular analysis of DLD gene; plasma amino acid and urine organic acid analysis during decompensation\",\n      \"journal\": \"Pediatric neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — enzymatic confirmation with molecular diagnosis in single patient; single lab\",\n      \"pmids\": [\"23290025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Mitochondrial dihydrolipoamide dehydrogenase (DLDH/DLD) functions as a redox enzyme involved in decarboxylation of pyruvate to acetyl-CoA during glucose metabolism and mitochondrial ATP production. Depending on physiological or pathophysiological conditions, DLDH can either enhance or attenuate production of reactive oxygen species (ROS) and reactive nitrogen species, positioning it as a potential therapeutic target for oxidative stress.\",\n      \"method\": \"Review of prior experimental work including inhibitor studies; mechanistic framework synthesis\",\n      \"journal\": \"Antioxidants\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — perspective/review article with no primary experimental data reported in the abstract\",\n      \"pmids\": [\"30717346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Suppression of the dld-1 gene (C. elegans ortholog of DLD) in a C. elegans model expressing human Aβ peptide in muscles or neurons significantly restored vitality and function degraded by Aβ pathology, and reduced formation of toxic Aβ oligomers without reducing total Aβ peptide abundance. Proteomics after dld-1 suppression showed changes in energy metabolism and activation of pathways associated with proteasomal degradation, improved cell signaling, and longevity. A mitochondrial uncoupler (FCCP) that similarly inhibits ATP synthesis had no significant effect on Aβ toxicity, implying that features unique to dld-1 suppression (beyond reduced ATP) mediate the protective effect.\",\n      \"method\": \"RNAi-mediated dld-1 suppression in C. elegans Aβ model; behavioral/functional assays; quantification of Aβ oligomers; proteomics analysis; FCCP comparator experiment\",\n      \"journal\": \"Genes & diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with defined phenotypic readout and orthogonal comparator (FCCP), plus proteomics; C. elegans ortholog study\",\n      \"pmids\": [\"34522713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Knockdown of DLD expression in ovarian cancer cells suppressed intracellular NAD+/NADH ratio and consequently suppressed tumor cell proliferation, demonstrating that DLD regulates metabolic flux through the TCA cycle in cancer cells.\",\n      \"method\": \"siRNA knockdown of DLD; NAD+/NADH ratio measurement; MTT cell proliferation assay\",\n      \"journal\": \"Oncology letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single knockdown experiment with two readouts but no mechanistic depth beyond metabolic ratio\",\n      \"pmids\": [\"37123026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DLD was identified as an interacting protein of CLTRN (collectrin) in HCC cells by co-immunoprecipitation, and the NRF1/RAN/DLD protein complex was proposed to act as an upstream regulator of CLTRN transcription. DLD was also linked to the glutathione metabolic pathway and ferroptosis signaling downstream of CLTRN overexpression.\",\n      \"method\": \"Co-immunoprecipitation; transcriptome sequencing (RNA-seq); in vitro and in vivo functional assays for ferroptosis markers\",\n      \"journal\": \"International journal of radiation oncology, biology, physics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — Co-IP identifying DLD as interacting protein is single method; mechanistic claims about DLD's role in the complex are not directly validated for DLD itself\",\n      \"pmids\": [\"33508374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DLD (dihydrolipoamide dehydrogenase) expression was decreased after UVB exposure in keratinocytes, and paeonol promoted DLD production, which was associated with activation of the Nrf2/antioxidant response element (ARE) pathway and prevention of procollagen type I degradation. This places DLD upstream of Nrf2/ARE activation in the antioxidant response to UVB stress.\",\n      \"method\": \"Western blotting for DLD protein expression; Nrf2 nuclear accumulation assay; NQO1 and HO-1 expression measurement; in vivo mouse skin photoaging model\",\n      \"journal\": \"Phytotherapy research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — correlative relationship between DLD expression changes and Nrf2 activation; no direct manipulation of DLD to establish causality\",\n      \"pmids\": [\"29748977\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DLD encodes the E3 subunit (dihydrolipoamide dehydrogenase) shared among four mitochondrial multienzyme complexes—pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain alpha-ketoacid dehydrogenase, and the glycine cleavage system—where it catalyzes oxidation of dihydrolipoyl moieties using FAD/NAD+ as cofactors; complete loss of DLD is embryonically lethal in mice, partial loss causes metabolic disease (lactic acidosis, organic acidemia, Leigh syndrome) in humans, and the protein modulates cellular ROS/NAD+/NADH balance and interacts with the Nrf2/ARE antioxidant pathway.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DLD encodes dihydrolipoamide dehydrogenase, the shared E3 flavoenzyme subunit common to four mitochondrial multienzyme complexes—pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase (KGDC), branched-chain alpha-ketoacid dehydrogenase, and the glycine cleavage system—as established genetically by murine knockout: complete loss causes perigastrulation embryonic lethality, while heterozygotes show coordinate ~50% reduction in E3 activity across all four complexes [#0]. Through this E3 activity DLD contributes to pyruvate decarboxylation, TCA-cycle flux, and mitochondrial ATP production, and its loss in cancer cells lowers the NAD+/NADH ratio and suppresses proliferation, linking the enzyme to cellular redox and metabolic balance [#6]. The protein interacts with partner E2 subunits and the E3-binding protein through an interface domain, and missense mutations clustering in this region (p.R482G, near p.D479V) can selectively impair KGDC, indicating that E3's engagement of its partner complexes is not uniform [#2]. In humans, hypomorphic DLD mutations causing reduced E3 activity produce dihydrolipoamide dehydrogenase deficiency presenting as Leigh syndrome with episodic encephalopathy and lactic ketoacidosis [#3]. The gene is transcriptionally configured for mitochondrial/respiratory function, with promoter elements including an NRF1 site [#1].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Before its regulation was understood, the genomic organization and promoter architecture of human DLD were undefined; mapping the gene established how this housekeeping mitochondrial enzyme is transcriptionally controlled.\",\n      \"evidence\": \"Restriction mapping, genomic sequencing, and primer extension of the human DLD locus\",\n      \"pmids\": [\"8406489\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional activity of the identified NRF1/Sp1/CRE elements not tested by reporter assays\", \"Does not address protein function or enzymatic mechanism\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"It was unclear whether a single E3 subunit served all dihydrolipoamide-dependent complexes; knockout established DLD as the obligate shared E3 for four mitochondrial complexes and as essential for embryogenesis.\",\n      \"evidence\": \"Homologous-recombination knockout in mice with enzymatic assays of E3 and all four complexes\",\n      \"pmids\": [\"9405644\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Embryonic lethality precludes analysis of tissue-specific roles\", \"Does not resolve how one E3 is shared among structurally distinct complexes\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Whether E3 interacts identically with each partner complex was unknown; an interface-domain mutation causing isolated KGDC deficiency showed E3-partner interactions differ among complexes.\",\n      \"evidence\": \"Enzyme assays and DLD sequencing in patient fibroblasts identifying p.R482G in the E2/E3-binding interface\",\n      \"pmids\": [\"15712224\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of selective KGDC impairment inferred from mutation location, not structurally resolved\", \"Differential binding affinities not measured directly\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"The clinical range of DLD deficiency was incompletely defined; compound-heterozygous patients extended the spectrum to include Leigh syndrome.\",\n      \"evidence\": \"Enzymatic and molecular diagnosis in fibroblasts with metabolite profiling during decompensation\",\n      \"pmids\": [\"23290025\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single patient; genotype-phenotype correlation not generalized\", \"Does not establish why residual E3 activity yields Leigh-type neuropathology\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Beyond catalysis, DLD's contribution to redox state was synthesized into a framework casting it as a bidirectional modulator of ROS/RNS and a possible oxidative-stress target.\",\n      \"evidence\": \"Review synthesis of prior inhibitor and mechanistic studies\",\n      \"pmids\": [\"30717346\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Review without new primary data\", \"Conditions determining ROS enhancement vs attenuation not defined experimentally here\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Whether reducing DLD activity has consequences beyond ATP loss was open; ortholog suppression in a C. elegans Abeta model conferred protection distinct from a metabolic uncoupler.\",\n      \"evidence\": \"RNAi of dld-1 in Abeta worms with behavioral assays, Abeta-oligomer quantification, proteomics, and FCCP comparator\",\n      \"pmids\": [\"34522713\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking dld-1 loss to reduced Abeta oligomerization unresolved\", \"Findings in worm ortholog not validated in mammalian neurons\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"DLD's potential involvement in transcriptional and ferroptosis circuitry was probed; it was identified as a CLTRN-interacting protein within a proposed NRF1/RAN/DLD complex linked to glutathione metabolism.\",\n      \"evidence\": \"Co-immunoprecipitation, RNA-seq, and ferroptosis-marker assays in HCC cells\",\n      \"pmids\": [\"33508374\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single Co-IP without reciprocal validation for DLD\", \"DLD's specific contribution to the complex's regulatory activity not directly tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"DLD's role in cancer metabolism was tested; knockdown lowered the NAD+/NADH ratio and suppressed proliferation, tying it to TCA-cycle flux in tumor cells.\",\n      \"evidence\": \"siRNA knockdown with NAD+/NADH measurement and proliferation assay in ovarian cancer cells\",\n      \"pmids\": [\"37123026\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single knockdown experiment without rescue\", \"Downstream effectors linking NAD+/NADH change to proliferation not identified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How E3/DLD switches between enhancing and attenuating ROS, and how its interface selectively engages distinct partner complexes, remains mechanistically unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of complex-specific E3 docking in the timeline\", \"Causal, redox-state-resolved control of ROS by DLD not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 4, 6]}\n    ],\n    \"complexes\": [\n      \"pyruvate dehydrogenase complex\",\n      \"alpha-ketoglutarate dehydrogenase complex\",\n      \"branched-chain alpha-ketoacid dehydrogenase complex\",\n      \"glycine cleavage system\"\n    ],\n    \"partners\": [\n      \"CLTRN\",\n      \"NRF1\",\n      \"RAN\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}